Peptides from wheat glladins, A-gliadin and prolamins from cereals toxic for coeliac patients agglutinate K 562(5) cells; they also damage in vitro cultured fetal rat intestine and atrophic coeliac mucosa. The largest COIIInon secp:nces among the In vitro active A-gliadin peptldes were -Pro-Ser-Cln-Clr,-and -(Cln)3-Pro-.The following peptldes all containing the aminoacld sequence -(Cln)3 -Prc have been synthesized: the pentapeptlde Tyr-(Cln)3 -Pro, Its dlmer and tetramer and the eptapeptide Cln-Pro-Tyr-(Cln)3 -Pro In their free and N-.cetylated forms and the Pyroglutamic deri.vate of the heptapeptide (Pyr7).Pyr 7 agglutinated cells and inhibited the in vitro development of fetal rat intestine (medium's concentration O.S"-2mg/ml);ft was non toxic on the in vitro cultured coeliac atrophic mucosa. The N-acetylated form of the pentapeptlde's tetr.mer (lmg/ml) also damaged the atrophic coeliac mucosa in 4 cultured biopsies. These results suggest that the sequence~(Cln)3-Pro when part of a larger peptide may be toxic in vitro for the atrophic coeliac mucosa. Diminished glucose production is the adult response to glucose infusion. Persistent glucose production in response to exogenous glucose is evidence of a transitional homeostatic state in the first days after birth. Glucose production (Ra) was measured in 11 infants (BW 1716±48 gms;_tA 3~io.3 wkS!3at 2-3 wks of age. In these paired studies, 4 ug·kg min D-(U-C)glucose tracer was infuse~lby efime constant infusion in saline or glucose (5.3±0.2 mg-kg min ) solution. Data was compared to that from 23 infants (BW 2017±69 gms; GA 34.±0.3 wks)previously studied at 1-2 days of age. The weiahts of the groups at time of study were comparable. When the results from the glucose turnover period were compared to the saline turnover period, plasma glucose concentration was elevated in the infants (97±vs. 64±5 mg/dl at 1-2 days and 101±4 vs. 88±31 mg/dl at 2-5 wks, respective ly)(p<.ool). When a similar comparison was made, plasma insulin concentration was elevated only in the younger infants (19±3 vs. 11±1 uU/m1 at 1-2 days (ei'P511and 12±5 vs. 8±3 uU/ml at 2-5 wks). Persistent Ra (~l mg·kg min during glucose infusion was similar between the 2 groups (5/13 infants at 1-2 days and 6/11 infants at 2-5 wks).Control of glucose kinetics is transitional throughout the neonatal period which may partially account for the frequency of hyperglycemia noted clinically. all depths of the outer leaflet of the lipid bilayer, i.e. a decrease in aeabrane fluidity. Ve deterained simultaneously fluorescence anisotropy, the cholesterol/phospholipid aolar ratio (C/P), and the distribution patterns of the aajor fatty acids of BBII during aaturation. C/P continuously increased: newborns .90t.16, sucklings 1.05t.13,  weaned 1.33t.16, juveniles 1.33t.30, adults 1.45t.15 . This increase closely paralleled the increase in fluorescence anisotropy aeasured with diphenylhexatriene as fluorophore. The relative contents of the fatty acid 16:0 decreased, while' 18:0 increased. The fatty acids 14:1, 16:1, and 18:1 decreased. OUr data indicate an elongation of saturated fatty acids during aaturation. They deaonstrate the rigidifying effect of cholesterol and the fluidifying effect of certain unsaturated fatty acids known froa artificial membranes to apply also to bio.eabranes. Children's Hospital and Human Genetics, FRG. A 2 year-old boy with hepatosplenomegaly and muscular hypotonia showed a deficient branching enzyme activity (BE) in fibroblasts (diagnosis confirmed by B. Brown, USA).We have investigated BE in erythrocytes (erys) by determination of phosphates released from glucose-l-p in the mixture containing phosphorylase. BE in erys was well measureable as debranching enzyme and phosphorylases.BE in erys of the patient was deficient (0-0.2 umol/min/g Hb vs. 4-16 in controls, n=75). Glycogen was not elevated in erys of the patient(4 mg/ dL; normal, 0-10). BE in erys from his mother was' app. 50 % of the normal range (2.92). Type IV glycogenosls was suspected by the pathological examination in a female patient who died of the respiratory distress syndrome 1 day after birth. BE in erys of his parents was 2.55 and 2.22 and in fibroblasts 0.14 and 0.35 umol/min/mg protein respectively (control fibroblasts, o.4-1.4,n=8).These results show that easily accessible heparinized blood is an excellent source for the homoand heterozygote detection of type IV glycogenosls.
DIET-INJUCED

BRANCHING ENZYME IN ERYTHROCYTES
A RETROSPECTIVE ANALYSIS OF THE GROWTH PATTERN OF 110 CHILDREN WITH HYPERPHENYLALANINEMIA (HPA).
112 J.H.Bramswig, S. Karassalidou, K.Ullrich, Univarsity Children's Hospital Munster, FRG Growth was assessed retrospectively in 110 children (49 boys, 61 girls) with HPA. They were 12.22 + 4.74 years (mean + SO) at the time of the last evaluation. B7 pts had the classical (type I), lB the mild form (type 2), 5 pts had persistent hyperphyenylalaninemia (type 3). Height was compared with the growth of normal children by calculation of the standarddeviation score (50S), using the data of Tanner et al. (1966) . The height-50S was similar in all three groups with 0.40 + 1.0 (type 1), 0.42 + :L06 (type 2) and 0.69 + 0.46 (type 3). in 27 pts the dietary regimen was discontinued at the age of B,Bl + 2.24 years with the height-50S being 0.18 + 1.19. At 16.02 + 1.55 years the height-SDS had not changed significantly with 0.4~!0.10 50S. 10 boys and 28 girls have reached final adult height. Boys measured 178.50 + 8.53 cm, girls 164.51 + 5.25 cm, which was 0.B5 + 4.74 and 3.64 + 7.32 em above target height with no significant difference between type 1 and 2. Our data demonstrate that growth is normal in the different forms of HPA and is not affected by discontinuation of the dietary regimen.
